Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Allergan Urgently Seeks FDA Guidance To Unblock Vraylar sNDA Review
Sep 25 2017
•
By
Sten Stovall
FDA BLOCKS VRAYLAR SNDA FOR TREATING NEGATIVE SCHIZOPHRENIA SYMPTOMS • Source: Shutterstock
More from New Products
More from Scrip